Oxford Immunotec Global
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch OXFD and buy or sell other stocks, ETFs, and their options commission-free!About OXFD
Oxford Immunotec Global Ltd. operates as a diagnostics company, which develops and commercializes proprietary tests for immunology and infectious disease. Its products include T-SPOT.TB, T-SPOT.CMV, T-SPOT.PRT and T-CELL XTEND.
CEOPhillip Anthony Keefe
CEOPhillip Anthony Keefe
Employees—
Employees—
HeadquartersAbingdon, Oxfordshire
HeadquartersAbingdon, Oxfordshire
Founded2002
Founded2002
Employees—
Employees—
OXFD Key Statistics
Market cap562.46M
Market cap562.46M
Price-Earnings ratio-32.73
Price-Earnings ratio-32.73
Dividend yield—
Dividend yield—
Average volume537.30K
Average volume537.30K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$23.11
52 Week high$23.11
52 Week low$8.37
52 Week low$8.37
Stock Snapshot
As of today, Oxford Immunotec Global(OXFD) shares are valued at $21.99. The company's market cap stands at 562.46M, with a P/E ratio of -32.73.
On 2026-01-01, Oxford Immunotec Global(OXFD) shares started trading at —, with intraday highs of — and lows of —.
Trading volume for Oxford Immunotec Global(OXFD) stock has reached 0, versus its average volume of 537.3K.
The stock's 52-week range extends from a low of $8.37 to a high of $23.11.
The stock's 52-week range extends from a low of $8.37 to a high of $23.11.
People also own
Based on the portfolios of people who own OXFD. This list is generated using Robinhood data, and it’s not a recommendation.